|
MARK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.992600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.041600E-03 |
| Normal-vs-Stage2 |
1.258980E-01 |
| Normal-vs-Stage3 |
8.04890000000169E-05 |
| Normal-vs-Stage4 |
1.154400E-04 |
| Stage1-vs-Stage2 |
3.113800E-01 |
| Stage1-vs-Stage3 |
1.624360E-01 |
| Stage1-vs-Stage4 |
1.206560E-01 |
| Stage2-vs-Stage3 |
5.807700E-02 |
| Stage2-vs-Stage4 |
4.352400E-02 |
| Stage3-vs-Stage4 |
6.257000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.196300E-04 |
| Normal-vs-AfricanAmerican |
5.377400E-01 |
| Normal-vs-Asian |
6.379700E-04 |
| Caucasian-vs-AfricanAmerican |
6.180000E-02 |
| Caucasian-vs-Asian |
5.377800E-01 |
| AfricanAmerican-vs-Asian |
3.067500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.50150000000671E-05 |
| Normal-vs-Female |
1.658940E-03 |
| Male-vs-Female |
8.446300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.060400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.284600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.82939999999943E-05 |
| Normal-vs-Age(81-100Yrs) |
4.058800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.851600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.473230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.290580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.101030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.538180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.887600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.377800E-03 |
| Classical-VS-Follicular |
6.047000E-01 |
| Classical-VS-Other |
2.153800E-01 |
| Classical-VS-Normal |
2.883700E-03 |
| Tall-VS-Follicular |
3.875900E-02 |
| Tall-VS-Other |
9.530400E-01 |
| Tall-VS-Normal |
2.14319999999324E-05 |
| Follicular-VS-Other |
4.115400E-01 |
| Follicular-VS-Normal |
1.029840E-02 |
| Other-VS-Normal |
2.028300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.404600E-03 |
| Normal-vs-N1 |
5.99529999978365E-07 |
| N0-vs-N1 |
2.621100E-03 |
|
|
